Company: RITM-PC
Filing Date: 2025-08-01
Form Type: 424B5
Source: 0001140361-25-028380
Chunk: 14

Company: Rithm Capital Corp.
Filing Date: 2025-08-01
Form: 424B5
Chunk 14
---
 the opportunity as part of your investment decision to assess whether the net proceeds are being used appropriately. Because the net proceeds are not required to be allocated to any specific investment or transaction, you cannot determine at this time the value or propriety of our application of the net proceeds and you may not agree with our decisions. The failure of our management to use these funds effectively could harm our business. Future sales or issuances of our common stock may dilute the ownership interest of existing shareholders and depress the trading price of our common stock. We cannot predict the effect, if any, that future sales of our common stock, including sales pursuant to the Distribution Agreement, or the availability of our common stock for future sale, will have on the market price of shares of our common stock. Future sales or issuances of our common stock may dilute the ownership interests of our existing shareholders, including purchasers of common stock in this offering. In addition, future sales or issuances of substantial amounts of our common stock may be at prices below the offering price of the shares offered by this prospectus supplement and may adversely impact the market price of our common stock and the terms upon which we may obtain additional equity financing in the future. The perception that such sales or issuances may occur could also negatively impact the market price of our common stock. Your percentage ownership in us may also be diluted in the future because of equity awards that we expect will be granted to our directors, officers and employees, as well as other equity instruments such as debt and equity financing. We have adopted the Rithm Capital Corp. 2023 Omnibus Incentive Plan (the “2023 Plan”), which provides for the grant of stock-based compensation to its officers and other employees and non-employee directors for the purpose of providing incentives and rewards for service or performance. Stock-based awards issued under the 2023 Plan include time-based and performance-based restricted stock unit awards and restricted stock awards and may include other forms of equity-based compensation. We reserved 34,240,000 shares of our common stock for issuance under the 2023 Plan. The 2023 Plan expires in 2033. As of June 30, 2025, rights relating to 19,693,700 shares of our common stock remain available under the 2023 Plan. There can be no assurance that the market for our stock will provide you with adequate liquidity. There can be no assurance that an active trading market for our common stock will be sustained in the future, and the market price of our common